Search results
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 1 day agos first-quarter expectations Thursday. The Covid vaccine maker came out of the March quarter with a...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 1 day agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 5 hours agoNet product sales plummeted by 91% compared to Q1 2023. This downturn aligns with the expected transition to a seasonal market for Covid-19 vaccines ...
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via AOL· 4 days agoBy the looks of it, this was only the beginning of the healthcare revolution that mRNA triggered. Mainz Biomed ...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 19 hours ago19), smaller than the consensus estimate loss of $(3.55). The company cut research and development...
Q&A: AstraZeneca's COVID-19 vaccine and blood clots—what you need to know
Medical Xpress· 2 days agoPharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 1 day agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via AOL· 1 day ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 15 hours agoModerna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells...
Moderna makes several cost-cutting moves, leans into AI - Boston Business Journal
The Business Journals· 24 hours agoAs Moderna Inc. works toward expanding its approved products beyond its Covid-19 vaccine, the...
